Taevas
BangladeshMedical Devices
Sales Support
Sales Support for Medical Devices in Bangladesh
Taevas Global equips medical devices manufacturers with on-the-ground sales infrastructure, DGDA-compliant market access strategies, and distributor networks to accelerate revenue generation in Bangladesh. From first contact to closed deal, we bridge the
Market
Bangladesh
Industry
Medical Devices
Service
Sales Support
Regulator
Directorate General of Drug Administration (DGDA)
Timeline
6-10 Weeks
What We Deliver
Six Pillars of Bangladesh Medical Devices Intelligence
Our six interconnected pillars give medical devices manufacturers a complete commercial foundation — from regulatory clearance through to active pipeline management — purpose-built for the Bangladesh market.
01
DGDA Regulatory Navigation
Bangladesh requires all medical devices to be registered with the Directorate General of Drug Administration before commercial sale. We map the exact registration pathway for your device class, prepare documentation packages, and liaise with local authorized agents to keep your timeline on track. Our team monitors DGDA policy updates so your sales process is never stalled by a compliance gap.
Device classification and registration roadmap under DGDA guidelines
Authorized local agent identification and onboarding
Ongoing regulatory monitoring and renewal management
How It Works
From Brief to Board-Ready Intelligence
Our four-step engagement moves from scoping your device and market objectives through to a live pipeline and actionable sales infrastructure — delivered in six to ten weeks.
Step 1 · Day 1-3
Discovery and Scoping
We begin with a structured intake session to understand your device category, regulatory status, target buyer segments, and commercial objectives for Bangladesh. This scoping call defines the exact deliverables, timelines, and success metrics for your engagement. A signed project brief is issued within 48 hours of the kickoff call.
Taevas Approach
During discovery we collect your existing regulatory documentation, pricing expectations, and any prior Bangladesh market intelligence. We also identify whether your device falls under DGDA Class A, B, C, or D classification, which determines the registration timeline and the urgency of the parallel sales preparation track. This foundation prevents rework at every later stage.
Market Snapshot
Bangladesh Medical Devices Market at a Glance
$0M+
Estimated Market Size (2024)
0%
Projected Annual Growth Rate
0+
Active Importers and Distributors
0+
Private Hospitals and Diagnostic Centers
Import-Dependent Market
Bangladesh imports over 90 percent of its medical devices, creating significant opportunity for foreign manufacturers. Local manufacturing is limited primarily to consumables and basic diagnostic equipment, meaning sophisticated devices face minimal domestic competition. This import dependence makes distributor relationships and DGDA registration the two most critical entry levers.
DGDA Registration is Mandatory
The Directorate General of Drug Administration requires all medical devices to be registered before commercial sale, and enforcement has tightened significantly since 2020. Registration timelines vary from three months for Class A devices to over twelve months for higher-risk Class C and D categories. Companies that begin registration in parallel with sales preparation consistently achieve faster revenue timelines.
Government Procurement Dominates Volume
Public sector procurement through the Directorate General of Health Services and Essential Drugs Company Limited accounts for a significant share of device purchasing by volume. Participating in government tenders requires local registration, a registered local agent, and competitive BDT pricing that accounts for import duties. Private hospital group procurement is growing rapidly and offers faster sales cycles.
Digital Health and Diagnostics Driving Growth
Bangladesh's expanding network of private diagnostic centers and the government's push toward universal health coverage are driving demand for imaging, point-of-care diagnostics, and patient monitoring devices. The rise of telemedicine infrastructure post-pandemic has also created new demand for connected diagnostic equipment in secondary and tertiary cities beyond Dhaka.
What's Included
Everything in Your Report
Every Sales Support engagement for Bangladesh Medical Devices delivers eight concrete outputs your team can act on immediately — from regulatory roadmaps to warm buyer introductions.
Bangladesh Sales Entry Strategy
A comprehensive written strategy covering your recommended go-to-market model, channel structure, buyer priority sequence, and 12-month sales roadmap for the Bangladesh medical devices market.
DGDA Registration Pathway Document
A step-by-step registration guide specific to your device class under DGDA regulations, including required documentation, authorized agent requirements, and realistic timeline milestones.
Distributor Due Diligence Shortlist
A ranked shortlist of five to eight vetted distribution partners with due diligence profiles covering their DGDA registration status, device portfolio, hospital access, financial standing, and proposed margin expectations.
Landed Cost and Pricing Model
A detailed financial model in BDT and USD showing your full cost-to-market including NBR import duties, VAT, distributor margin, and recommended retail and tender pricing bands.
Key Account and Buyer Contact Map
A prioritized map of hospital groups, diagnostic chains, government procurement bodies, and NGO health programs with named procurement contacts, buying cycles, and current supplier intelligence.
Localized Sales Collateral Package
Bengali and English adapted product one-pagers, clinical evidence summaries, and a tender response template — all reviewed for compliance with DGDA promotion guidelines.
Competitive Landscape Analysis
A structured analysis of competing imported and locally available devices in your category, covering pricing, distributor relationships, DGDA registration status, and key differentiators to exploit.
CRM-Ready Bangladesh Pipeline Tracker
A pre-populated pipeline tracker in your preferred CRM or spreadsheet format covering all warm introductions made during activation, with contact details, meeting notes, deal stage, and recommended next actions.
Who This Is For
Built for These Situations
Market Entry
First-Time Entrant to Bangladesh
You manufacture medical devices outside Bangladesh and have identified the country as a priority growth market but have no local presence, no distributor, and no DGDA registration in place. You need a structured entry plan that moves from zero to a live sales pipeline without the risk of costly missteps in an unfamiliar regulatory and commercial environment. Taevas Global builds your entire Bangladesh commercial foundation from scratch.
Outcome
A fully operational Bangladesh sales infrastructure — registered, distributed, and pipeline-active — within ten weeks of engagement start.
Next Steps
After Sales Support, Most Clients Move To
FAQ
Common Questions
Get Started
Ready to Map Your Bangladesh Opportunity?
Taevas Global's Sales Support engagement gives medical devices manufacturers a complete, DGDA-compliant commercial foundation in Bangladesh — from regulatory pathway through to a live distributor network and active buyer pipeline. Speak with our team today to scope your engagement.
DGDA registration pathway tailored to your device class and timeline
Vetted distributor shortlist with due diligence profiles ready for negotiation
Pre-qualified buyer pipeline with warm introductions to hospital and government accounts
Localized sales collateral and pricing model built for the Bangladesh market